Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Robbins

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Nature Reviews. Immunology|June 2, 2026
Hallmarks and correlates of effective adoptive cell immunotherapy for cancerSri Krishna, Paul F Robbins, Frank J Lowery, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanomaJuhua Zhou, Mark E Dudley, Steven A Rosenberg, et al.
Blood|September 4, 2004
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapyDaniel J Powell, Mark E Dudley, Paul F Robbins, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant proteinMaria R Parkhurst, John P Riley, Paul F Robbins, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanomaStephanie L Goff, Paul F Robbins, Mona El-Gamil, et al.
Environmental Management|July 20, 2007
Enforcement authority and vegetation change at Kumbhalgarh wildlife sanctuary, Rajasthan, IndiaPaul F Robbins, Anil K Chhangani, Jennifer Rice, et al.
Cancer Research|October 30, 2003
Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytesCristina Maccalli, Yong F Li, Mona El-Gamil, et al.
European Journal of Immunology|July 30, 2003
NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activityCristina Maccalli, Daniela Pende, Chiara Castelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapyJuhua Zhou, Xinglei Shen, Jianping Huang, et al.
Cancer Research|October 17, 2012
Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinomaQiong J Wang, Ken-Ichi Hanada, Paul F Robbins, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Nature Reviews. Immunology|June 2, 2026
Hallmarks and correlates of effective adoptive cell immunotherapy for cancerSri Krishna, Paul F Robbins, Frank J Lowery, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanomaJuhua Zhou, Mark E Dudley, Steven A Rosenberg, et al.
Blood|September 4, 2004
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapyDaniel J Powell, Mark E Dudley, Paul F Robbins, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant proteinMaria R Parkhurst, John P Riley, Paul F Robbins, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanomaStephanie L Goff, Paul F Robbins, Mona El-Gamil, et al.
Environmental Management|July 20, 2007
Enforcement authority and vegetation change at Kumbhalgarh wildlife sanctuary, Rajasthan, IndiaPaul F Robbins, Anil K Chhangani, Jennifer Rice, et al.
Cancer Research|October 30, 2003
Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytesCristina Maccalli, Yong F Li, Mona El-Gamil, et al.
European Journal of Immunology|July 30, 2003
NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activityCristina Maccalli, Daniela Pende, Chiara Castelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapyJuhua Zhou, Xinglei Shen, Jianping Huang, et al.
Cancer Research|October 17, 2012
Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinomaQiong J Wang, Ken-Ichi Hanada, Paul F Robbins, et al.
Pageof 13